LRRK1 Protein - Leucine-Rich Repeat Kinase 1

LRRK1 Protein - Leucine-Rich Repeat Kinase 1

Introduction

Lrrk1 Protein Leucine Rich Repeat Kinase 1 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

Leucine-Rich Repeat Kinase 1 (LRRK1) is a large multi-domain protein with serine/threonine kinase activity that plays important roles in membrane trafficking, cytoskeletal dynamics, and cellular signaling[@marin2008]. While LRRK2 is more extensively studied in Parkinson's disease (PD), LRRK1 has emerged as a significant modifier of LRRK2 function and is itself implicated in PD pathogenesis, bone metabolism disorders, and cancer[@gilsbach2012].

LRRK1 Protein - Leucine-Rich Repeat Kinase 1

Introduction

Lrrk1 Protein Leucine Rich Repeat Kinase 1 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

Leucine-Rich Repeat Kinase 1 (LRRK1) is a large multi-domain protein with serine/threonine kinase activity that plays important roles in membrane trafficking, cytoskeletal dynamics, and cellular signaling[@marin2008]. While LRRK2 is more extensively studied in Parkinson's disease (PD), LRRK1 has emerged as a significant modifier of LRRK2 function and is itself implicated in PD pathogenesis, bone metabolism disorders, and cancer[@gilsbach2012].

<div class="infobox infobox-protein">
<table>
<tr><th colspan="2" style="background:#f0f0f0;">LRRK1 Protein</th></tr>
<tr><td><strong>Protein Name</strong></td><td>Leucine-Rich Repeat Kinase 1</td></tr>
<tr><td><strong>Gene</strong></td><td>[LRRK1](/genes/lrrk1)</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[Q8IW41](https://www.uniprot.org/uniprot/Q8IW41)</td></tr>
<tr><td><strong>PDB ID(s)</strong></td><td>5DNO, 5DNR</td></tr>
<tr><td><strong>Molecular Weight</strong></td><td>278.5 kDa</td></tr>
<tr><td><strong>Subcellular Localization</strong></td><td>Cytoplasm, endosomal membranes</td></tr>
<tr><td><strong>Protein Family</strong></td><td>LRRK family</td></tr>
<tr><td><strong>Expression</strong></td><td>Broad tissue distribution (brain, bone, immune cells)</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/parkinson" style="color:#ef9a9a">Parkinson</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">9 edges</a></td>
</tr>
</table>
</div>

Structure

Domain Architecture

LRRK1 contains multiple functional domains characteristic of the ROCO protein family[@deng2011]:

Comparison with LRRK2

| Feature | LRRK1 | LRRK2 |
|---------|-------|-------|
| Molecular weight | 278 kDa | 286 kDa |
| GTPase activity | Lower | Higher |
| Kinase activity | Lower | Higher |
| PD mutations | Less common | Common (G2019S) |
| Expression | Broader | Brain-enriched |

Function

Kinase Activity

• Substrate specificity: Phosphorylates serine/threonine residues
• Autophosphorylation: Can autophosphorylate
• Regulation: Kinase activity modulated by GTP binding to ROC domain

Cellular Functions

• Endolysosomal trafficking: Regulates vesicle movement and fusion
• Cytoskeletal dynamics: Affects microtubule organization
• [Autophagy](/entities/autophagy): Modulates autophagosome formation
• Immune signaling: Involved in TLR signaling pathways

Interaction with LRRK2

LRRK1 and LRRK2 exhibit functional interactions[@biskup2006]:

• Compensation: LRRK1 can partially compensate for LRRK2 loss
• Dimerization: Can form heterodimers
• Substrate sharing: May phosphorylate common substrates
• Pathogenic synergy: Combined dysfunction may increase PD risk

Role in Disease

Parkinson's Disease

LRRK1 involvement in PD is emerging[@hanna2020]:

• Genetic association: LRRK1 variants modify PD risk
• LRRK2 interaction: LRRK1 deficiency enhances LRRK2 G2019S toxicity
• Dopaminergic [neurons](/entities/neurons): Expressed in substantia nigra pars compacta
• Synaptic function: Regulates synaptic vesicle cycling

Osteoporosis-Parkinsonism Syndrome

Biallelic LRRK1 mutations cause a rare syndrome:

• Features: Early-onset Parkinson's, osteoporosis, fractures
• Inheritance: Autosomal recessive
• Mechanism: Loss of LRRK1 kinase function

Cancer

• Breast cancer: LRRK1 mutations in some cases
• Colorectal cancer: Overexpression in some tumors
• Cell proliferation: Role in cell cycle progression

Therapeutic Approaches

Kinase Inhibitors

• LRRK2 inhibitors: May indirectly affect LRRK1
• Selectivity challenges: LRRK1/2 similarity makes selective targeting difficult

Gene Therapy

• AAV-LRRK1: Potential for restoring function
• CRISPR: Correcting pathogenic variants

See Also

• [LRRK1 Gene](/proteins/lrrk1-protein)
• [LRRK2 Gene](/proteins/lrrk2-protein)
• [LRRK2 Protein](/proteins/lrrk2-protein)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Kinase Signaling Pathways](/mechanisms/kinase-signaling-pathways)
• [Dopaminergic Vulnerability Pathway](/mechanisms/dopaminergic-vulnerability)

External Links

• [UniProt Q8IW41](https://www.uniprot.org/uniprot/Q8IW41)
• [PDB: LRRK1 Kinase Domain](https://www.rcsb.org/structure/5DNO)
• [LRRK1 in disease - Nature Reviews](https://pubmed.ncbi.nlm.nih.gov/29885285/)

Background

The study of Lrrk1 Protein Leucine Rich Repeat Kinase 1 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

References